Johnson & Johnson (NEO:JNJ)

Canada flag Canada · Delayed Price · Currency is CAD
20.89
+0.41 (2.00%)
Apr 3, 2025, 9:30 AM EST
-1.46%
Market Cap 535.86B
Revenue (ttm) 128.02B
Net Income (ttm) 20.27B
Shares Out n/a
EPS (ttm) 8.35
PE Ratio 26.43
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 5,810
Open 20.89
Previous Close 20.48
Day's Range 20.89 - 20.89
52-Week Range 18.75 - 22.50
Beta 0.52
RSI 44.21
Earnings Date Apr 15, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Cboe Canada
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.